Gaucher disease trials in Netherlands

2 of 3 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 4Not yet taking people in Netherlands
  ONCE: Once daily eliglustat in stable CYP2D6 intermediate and extensive metabolizers with Gaucher disease type 1

  Where

  Amsterdam

  Age

  18 years and over

  People

  7

  Run by

  Amsterdam UMC Stichting

  See details and how to join2026-527117-33-00
• Phase 3Taking people
  Effectiveness of ambroxol in children and adults with Gaucher disease 3: n-of-1 series

  Where

  Amsterdam

  Age

  Up to 64 years

  People

  4

  Run by

  Amsterdam UMC Stichting

  See details and how to join2024-514012-28-00